NCT03090672View on ClinicalTrials.gov

Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease

NAUnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 11, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

December 31, 2022

Conditions
OsteoarthritisRheumatoid NoduleDegenerative Joint DiseaseTendinopathyTendinosisBack Pain
Interventions
DRUG

Normal Saline

Normal Saline IV delivery

PROCEDURE

Tissue Stromal Vascular Fraction

tSVF

BIOLOGICAL

Platelet Rich Plasma

PRP

PROCEDURE

Cellular Stromal Vascular Fraction

cSVF

Trial Locations (2)

02760

RECRUITING

Regeneris Medical, North Attleboro

RECRUITING

Regeneris Medical, North Attleboro

Sponsors

Collaborators (1)

Regeneris Medical
All Listed Sponsors
collaborator

Regeneris Medical

OTHER

collaborator

Global Alliance for Regenerative Medicine

OTHER

lead

Robert W Alexander, MD

OTHER

NCT03090672 - Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease | Biotech Hunter | Biotech Hunter